Hotspot mutations of the telomerase reverse transcriptase (TERT) promoter are frequently identified in primary tumors from patients with various types of bladder cancer and tumor stages, including precancerous lesions [7, 8, 9, 10, 11, 12, 13]. The gene discussed is TERT; the disease is urinary bladder carcinoma.